drugset / Trial / NCT00233935
Defined Green Tea Catechin Extract in Preventing Esophageal Cancer in Patients With Barrett's Esophagus
RandomizedParallel-groupTriple-blindPrevention
Summary
The goal of this clinical research study is to test the safety of defined green tea catechin extract at different dose levels. Researchers also want to find out what effects, good and bad, it may have on individual and their risk for esophagus cancer. Esophagus cancer is an increased risk associated with Barrett's esophagus. Chemoprevention is the use of certain drugs to keep cancer from forming, growing, or coming back. The use of defined green tea catechin extract may prevent esophageal cancer.
Timeline
- Start
- 2005-11
- Primary completion
- 2010-11
- Completion
- 2010-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sinecatechins | Unknown | 200 mg | Oral |
| Subject | Sinecatechins | Unknown | 400 mg | Oral |
| Subject | Sinecatechins | Unknown | 600 mg | Oral |